J&J wins Tremfya label expansion for joint damage in PsA (JNJ)
· seekingalpha.com
Johnson & Johnson (JNJ) stock is in focus as the FDA expands the Tremfya label to prevent further joint damage in psoriatic arthritis. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...